Stay updated on Aducanumab for Early Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.

Latest updates to the Aducanumab for Early Alzheimer's: Clinical Trial page
- Check5 days agoChange DetectedA site-wide NIH transition notice appears above the 403 error page, and the displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe footer now displays website revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now displays a 403 Forbidden message and minimal navigation, removing access to the full study record details and related resources.SummaryDifference17%

- Check40 days agoChange DetectedThe page shows Revision: v3.7.0 replacing Revision: v3.6.6. This represents a system or UI update, not changes to the study text.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, signaling a minor patch or update to the page or its underlying tooling. This update does not change the study details or visible content.SummaryDifference0.0%

- Check62 days agoChange DetectedThe 'Other Study ID Numbers' section now includes '2015 ( U.S. NIH Grant/Contract )', indicating NIH funding for the study. This addition provides context about the funding source associated with the trial.SummaryDifference0.0%

Stay in the know with updates to Aducanumab for Early Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.